ask="4.81"
ask_size="200"
average_daily_volume="268716"
bid="3.40"
bid_size="8800"
book_value="0.56"
change="+0.17"
change_from_200_day_moving_average="1.61"
change_from_50_day_moving_average="1.06"
change_from_52_week_high="-0.55"
change_From_52_week_low="2.09"
change_in_percent="+4.27%"
close="4.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.15"
high_52_weeks="4.70"
last_trade_date="2/24/2017"
last_trade_price="4.15"
last_trade_size="758"
last_trade_time="4:00pm"
low="3.52"
low_52_weeks="2.06"
market_capitalization="77.55M"
moving_average_200_day="2.54"
moving_average_50_day="3.09"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="4.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+63.13%"
percent_change_from_50_day_moving_average="+34.16%"
percent_change_from_52_week_high="-11.70%"
percent_change_from_52_week_low="+101.46%"
previous_close="3.98"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.07"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="7.59"
stock_exchange="NCM"
symbol="BCLI"
volume="347457"
weeks_range_52="2.06 - 4.70"
